EUVIMEDEUVIMED entdecken
EvaluationsstudieOpen Access · CC BY 4.0

Evaluation of gradient strip diffusion for susceptibility testing of aztreonam–avibactam in metallo-β-lactamase-producing Enterobacterales

Jamie K Lemon, Cheryl Jankowsi-Romano, Scott Duong, Stefan Juretschko, Vincent A Streva iD

Journal of Clinical Microbiology · 13.11.2024 · 62 (11)

DOI: 10.1128/jcm.00649-24 ↗

Kurz gefasst

Evaluationsstudie in der Zeitschrift Journal of Clinical Microbiology, erschienen am 13.11.2024. Verfasst von Jamie K Lemon und 4 weiteren Autor:innen. Beteiligte Einrichtung: Northwell Health Clinical Laboratories, New York, New York, USA. Hauptthemen laut MEDLINE: Aztreonam, Azabicyclo Compounds, Enterobacteriaceae, Anti-Bacterial Agents. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The emergence of metallo-β-lactamase (MBL)-producing Enterobacterales presents unique clinical treatment challenges. Recently developed β-lactam/ β-lactamase inhibitor combination agents, while effective against other carbapenemase-producing organisms, are notably ineffective against MBL producers. While MBLs do not hydrolyze monobactams (aztreonam), many MBL-producing organisms are resistant to aztreonam through alternate mechanisms, leaving cefiderocol as the sole monotherapy treatment option recommended for MBL producers. Recent guidelines for the treatment of MBL-harboring organisms have added combination therapy with aztreonam and ceftazidime–avibactam, using ceftazidime–avibactam as a source of the β-lactamase inhibitor avibactam. Current laboratory testing options for the combination of aztreonam–avibactam are limited to broth microdilution (BMD) and broth disk elution (BDE) methods, which are not practical in most clinical laboratories. In this study, we evaluated the performance of aztreonam/avibactam gradient strips on 103 MBL-producing Enterobacterales patient isolates as well as an additional 31 isolates from the CDC AR Bank. All MBL Enterobacterales patient isolates included in this study harbored a New Delhi metallo-β-lactamase ( bla NDM ) gene. Essential agreement of gradient strip minimal inhibitory concentrations (MICs) for patient isolates compared to BMD was 93.2%. While there are no established breakpoints for aztreonam–avibactam, category agreement (CA) for patient isolates was 97.1% when using the CLSI aztreonam breakpoints. There were no major or very major errors observed. There were three minor errors. Precision for aztreonam–avibactam gradient strip diffusion was 100%. These data demonstrate that the use of gradient strip diffusion for aztreonam–avibactam MIC determination in MBL-producing Enterobacterales is a viable option for clinical laboratories.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AztreonamAzabicyclo CompoundsEnterobacteriaceaeAnti-Bacterial Agentsbeta-LactamasesMicrobial Sensitivity TestsDrug CombinationsHumansbeta-Lactamase InhibitorsEnterobacteriaceae Infections

Stichwörter der Autor:innen

NDMantimicrobial susceptibility testingaztreonam–avibactamgradient strip diffusionmetallo-beta-lactamase

Substanzen

AztreonamAzabicyclo CompoundsAnti-Bacterial Agentsbeta-LactamasesDrug Combinationsbeta-Lactamase Inhibitorsavibactam

Autor:innen und Institutionen

  • Northwell Health Clinical Laboratories, New York, New York, USA.
  • Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Uniondale, New York, USA.

ORCID-Profile: Vincent A Streva

Zitieren

APA

Lemon, J. K., Jankowsi-Romano, C., Duong, S., Juretschko, S., & Streva, V. A. (2024). Evaluation of gradient strip diffusion for susceptibility testing of aztreonam–avibactam in metallo-β-lactamase-producing Enterobacterales. Journal of Clinical Microbiology, 62(11). https://doi.org/10.1128/jcm.00649-24

Vancouver

Lemon JK, Jankowsi-Romano C, Duong S, Juretschko S, Streva VA. Evaluation of gradient strip diffusion for susceptibility testing of aztreonam–avibactam in metallo-β-lactamase-producing Enterobacterales. Journal of Clinical Microbiology. 2024;62(11). doi:10.1128/jcm.00649-24

BibTeX
@article{Lemon2024,
  author = {Lemon, Jamie K and Jankowsi-Romano, Cheryl and Duong, Scott and Juretschko, Stefan and Streva, Vincent A},
  title = {Evaluation of gradient strip diffusion for susceptibility testing of aztreonam–avibactam in metallo-β-lactamase-producing Enterobacterales},
  journal = {Journal of Clinical Microbiology},
  year = {2024},
  volume = {62},
  number = {11},
  doi = {10.1128/jcm.00649-24}
}
Kostenlos starten →